RVL Pharmaceuticals Plc (OSMT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Eiger BioPharmaceuticals, Inc.

Lipocine, Inc.

Scorpius Holdings, Inc.

Mangoceuticals, Inc.

NanoViricides, Inc.

Edesa Biotech, Inc.

Moleculin Biotech, Inc.

Mustang Bio, Inc.

Virios Therapeutics, Inc.

Aprea Therapeutics, Inc.

RVL Pharmaceuticals Plc

Why is RVL Pharmaceuticals Plc ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-37.80%

EBIT Growth (5y)

-195.74%

EBIT to Interest (avg)

-11.23

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

2.38

Sales to Capital Employed (avg)

0.45

Tax Ratio

0.40%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

23.91%

ROCE (avg)

0.69%

ROE (avg)

0.94%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

-0.89

EV to EBITDA

-0.90

EV to Capital Employed

0.70

EV to Sales

1.05

PEG Ratio

Dividend Yield

ROCE (Latest)

-79.05%

ROE (Latest)

-229.87%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for RVL Pharmaceuticals Plc

Operating Profit

Highest at USD -8.03 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Operating Profit Margin

Highest at -97.2 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

At USD -7.76 MM has Grown at 51.55%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -7.65 MM has Grown at 53.07%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost

Fallen by -3.83% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for RVL Pharmaceuticals Plc

Net Sales

Lowest at USD 8.26 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

EPS

Lowest at USD -0.24

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debt-Equity Ratio

Highest at 238.81 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio